000 01286 a2200385 4500
005 20250512213314.0
264 0 _c19840316
008 198403s 0 0 eng d
022 _a0033-3158
024 7 _a10.1007/BF00426381
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShvartsburd, A
245 0 0 _aRed blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
_h[electronic resource]
260 _bPsychopharmacology
_c1984
300 _a55-61 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAging
650 0 4 _aChromatography, Gas
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aErythrocytes
_xmetabolism
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMesoridazine
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aSpectrometry, Fluorescence
650 0 4 _aThioridazine
_xblood
700 1 _aNwokeafor, V
700 1 _aSmith, R C
773 0 _tPsychopharmacology
_gvol. 82
_gno. 1-2
_gp. 55-61
856 4 0 _uhttps://doi.org/10.1007/BF00426381
_zAvailable from publisher's website
999 _c6420720
_d6420720